Cell cyclins: Triggering elements of cancer or not?

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Stamatakos, Michael ^a   Palla, Victoria ^a   Karaiskos, Ioannis ^a   Xiromeritis, Konstantinos ^a   Alexiou, Ioannis ^a   Pateras, Ioannis ^a   Kontzoglou, Konstantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN E; CYCLINE;

CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; NEOPLASM; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; CELL CYCLE; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; CELL CYCLE; CYCLINS; HUMANS; NEOPLASMS;

EID: 78650361663     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-111     Document Type: Review

References (55)

1. Nugent JH, Alfa CE, Young T, Hyams JS. Conserved structural motifs in cyclins identified by sequence analysis. J Cell Sci 1991, 99:669-674.
2. Pathway Central Cyclins and Cell Cycle Regulation. Pathway Central., http://www.sabiosciences.com/pathway.php
3. Traganos F. Cycling without cyclins. Cell Cycle 2004, 3:32-34. 10.4161/cc.3.1.608, 14657661.
4. Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest 1999, 104:1645-1653. 10.1172/JCI9054, 409893, 10606615.
5. Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW. Cell cycle-regulated phosphorylation of p220NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev 2000, 14:2298-2313. 10.1101/gad.829500, 316935, 10995387.
6. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: Normal and Abnormal Functions. Endocrinology 2004, 145:5439-5447. 10.1210/en.2004-0959, 15331580.
7. Rao SS, Kohtz DS. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic helix-loop-helix regulators. Mol Cell Biol 1994, 14:5259-5267. 359045, 8035804.
8. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine -286 prevents its rapid degradation via the ubiquitin - proteosome pathway. Genes Dev 1997, 11:957-972. 10.1101/gad.11.8.957, 9136925.
9. Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 2009, 220:292-296. 10.1002/jcp.21791, 2874239, 19415697.
10. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biology and Therapy 2002, 1:226-231.
11. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998, 95:1091-1096. 10.1073/pnas.95.3.1091, 18683, 9448290.
12. Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao TP, Pestell RG. Cyclin D1 inhibits peroxisome proliferator - activator gamma- mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 2005, 280:16934-16941. 10.1074/jbc.M500403200, 15713663.
13. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997, 17:5338-5347. 232384, 9271411.
14. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 2007, 98:629-635. 10.1111/j.1349-7006.2007.00449.x, 17359287.
15. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006, 26:5449-5469. 10.1128/MCB.02074-05, 1592725, 16809779.
16. Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: Implication of tumor vascularization. Clin Cancer Res 2006, 12:4720-4729. 10.1158/1078-0432.CCR-05-1213, 16899623.
17. Van Dross R, Browning PJ, Pelling JC. Do truncated cyclins contribute to aberrant cyclin expression in cancer?. Cell Cycle 2006, 5:472-477. 10.4161/cc.5.5.2516, 16552186.
18. Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 2001, 158(4):1355-1362. 1891928, 11290553.
19. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 2001, 107:1093-1102. 10.1172/JCI10523, 209274, 11342573.
20. Aref S, Mossad Y, El -Khodary T, Awad M, El-Shahat E. Cyclin D1 expression in B-cell non Hodgkin lymphoma. Hematology 2006, 11:365-370. 10.1080/10245330600841097, 17607588.
21. Liu H, Huang J, Wang J, Jiang S, Bailey AS, Goldman DC, Welcker M, Bedell V, Slovak ML, Clurman B, Thayer M, Fleming WH, Epner E. Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma. J Exp Med 2008, 205:1843-1858. 10.1084/jem.20072102, 2525596, 18625744.
22. Shakir R, Ngo N, Naresh KN. Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma. J Clin Pathol 2008, 61:920-927. 10.1136/jcp.2008.057455, 18552173.
23. Wang M, Sun L, Qian J, Han X, Zhang L, Lin P, Cai Z, Yi Q. Cyclin D1 as a universally expressed mantle cell lymphoma - associated tumour antigen for immunotherapy. Leukemia 2009, 23:1320-1328. 10.1038/leu.2009.19, 19225534.
24. Metcalf RA, Zhao S, Anderson MW, Lu ZS Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunan Y. Characterization of D - cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin - D2 and D3 expression in lymphoma subtypes. Mod Pathol 2010, 23:420-433. 10.1038/modpathol.2009.173, 2831151, 20062012.
25. Abboudi Z, Patel K, Naresh KN. Cyclin D1 expression in typical chronic lymphocytic leukaemia. Eur J Haematol 2009, 83:203-207. 10.1111/j.1600-0609.2009.01276.x, 19467018.
26. Alao JP, Gamble SC, Stavropoulou AV, Pomeranz KM, Lam EW, Coombes RC, Vigushin DM. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer 2006, 17:7.
27. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestall RG, Quong JN, Quong AA. Cyclin D1/cyclin dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 2010, 70:2105-2114. 10.1158/0008-5472.CAN-08-1108, 20179208.
28. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 2003, 78:323-335. 10.1023/A:1023033708204, 12755491.
29. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991, 66:1217-1228. 10.1016/0092-8674(91)90044-Y, 1833068.
30. Demetrick DJ, Matsumoto S, Hannon GJ, Okamoto K, Xiong Y, Zhang H, Beach DH. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC). Cytogenet Cell Genet 1995, 69:190-192. 10.1159/000133960, 7698009.
31. Mumberg D, Wick M, Burger C, Haas K, Funk M, Muller R. Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Research 1997, 25:2098-2105. 10.1093/nar/25.11.2098, 146711, 9153308.
32. Porter DC, Keyomarsi K. Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Research 2000, 28:E101. 10.1093/nar/28.23.e101, 115185, 11095697.
33. Keyomarsi K, Herliczek TW. The role of cyclin E in cell proliferation, development and cancer. Prog Cell Cycle Res 1997, 3:171-191.
34. Geisen C, Moroy T. The oncogenic activity of cyclin E is not confirmed to Cdk2 activation alone but relies on several other, distinct functions of the protein. J Biol Chem 2002, 277:39909-39918. 10.1074/jbc.M205919200, 12149264.
35. Marone M, Scambia G, Giannitelli C, Ferrandina G, Masciullo V, Bellacosa A, Benedetti-Panici P, Mancuso S. Analysis of cyclin E and Cdk2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 1998, 75:34-39. 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.0.CO;2-2, 9426687.
36. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993, 90:1112-1116. 10.1073/pnas.90.3.1112, 45821, 8430082.
37. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8:2127-2133.
38. Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K, Peschle C. Activation of human B-MYB by cyclins. Proc Natl Acad Sci USA 1997, 94:532-536. 10.1073/pnas.94.2.532, 19547, 9012818.
39. Ruesch MN, Laimins LA. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J Virol 1997, 71:5570-5578. 191799, 9188631.
40. Bresnahan WA, Boldgh I, Thompson EA, Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996, 224:150-160. 10.1006/viro.1996.0516, 8862409.
41. Kundu M, Sharma S, De LA, Giordano A, Rappaport J, Khalili K, Amini S. HIV-1 Tat elongates the G1 phase and indirectly promotes HIV 1 gene expression in cells of glial origin. J Biol Chem 1998, 273:8130-8136. 10.1074/jbc.273.14.8130, 9525916.
42. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994, 54:380-385.
43. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 2009, 8:1062-1068. 2692060, 19305161.
44. Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S, Keyomarsi K. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001, 2:6254-6269.
45. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS. Cyclin E and survival in patients with breast cancer. NEJM 2002, 347:1566-1575. 10.1056/NEJMoa021153, 12432043.
46. Bedrosian I, Lu KH, Verschraegen C, Keyomarsi K. Cyclin E deregulation alters the biologic properties of ovarian cancer cells. Oncogene 2004, 23:2648-2657. 10.1038/sj.onc.1207408, 15007381.
47. Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995, 75:1410-1417. 10.1002/1097-0142(19950315)75:6+<1410::AID-CNCR2820751504>3.0.CO;2-O, 7889467.
48. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1996, 1:88-94.
49. Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T, Tahara E. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 1995, 62:25-28. 10.1002/ijc.2910620107, 7601562.
50. Li JQ, Miki H, Ohmori M, Wu F, Funamoto Y. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum Pathol 2001, 32:945-953. 10.1053/hupa.2001.27116, 11567224.
51. Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch 1996, 429(1):13-19. 10.1007/BF00196815, 8865848.
52. Tang L, Li G, Tron VA, Trotter MJ, Ho VC. Expression of cell cycle regulators in human cutaneous malignant melanoma. Melanoma Res 1999, 9:148-154. 10.1097/00008390-199904000-00006, 10380937.
53. Bales E, Mills L, Milam N, McGahren-Murray M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi K, Medrano EE. The Low Molecular Weight Cyclin E Isoforms Augment Angiogenesis and Metastasis of Human Melanoma Cells In vivo. Cancer Research 2005, 65:692-697.
54. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM. Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non-Small Cell Lung Cancer: A Review. Clin Cancer Res 2005, 11:3974-3986. 10.1158/1078-0432.CCR-04-2661, 15930332.
55. Johansson M, Persson JL. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med Chem 2008, 8:723-731.